[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0907595A2 - Combinação de um quelante de ferro e um imunossupressor e uso dos mesmos - Google Patents

Combinação de um quelante de ferro e um imunossupressor e uso dos mesmos

Info

Publication number
BRPI0907595A2
BRPI0907595A2 BRPI0907595-0A BRPI0907595A BRPI0907595A2 BR PI0907595 A2 BRPI0907595 A2 BR PI0907595A2 BR PI0907595 A BRPI0907595 A BR PI0907595A BR PI0907595 A2 BRPI0907595 A2 BR PI0907595A2
Authority
BR
Brazil
Prior art keywords
immunosuppressant
combination
iron chelator
chelator
iron
Prior art date
Application number
BRPI0907595-0A
Other languages
English (en)
Inventor
Oliver Leismann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0907595A2 publication Critical patent/BRPI0907595A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0907595-0A 2008-02-19 2009-02-18 Combinação de um quelante de ferro e um imunossupressor e uso dos mesmos BRPI0907595A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08151642 2008-02-19
PCT/EP2009/051901 WO2009103727A2 (en) 2008-02-19 2009-02-18 Combination of an iron chelator and an immunosuppressant and use thereof

Publications (1)

Publication Number Publication Date
BRPI0907595A2 true BRPI0907595A2 (pt) 2015-07-21

Family

ID=39512801

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907595-0A BRPI0907595A2 (pt) 2008-02-19 2009-02-18 Combinação de um quelante de ferro e um imunossupressor e uso dos mesmos

Country Status (10)

Country Link
US (1) US20110009340A1 (pt)
EP (1) EP2254599A2 (pt)
JP (1) JP2011512383A (pt)
KR (1) KR20100126386A (pt)
CN (1) CN101945668A (pt)
AU (1) AU2009216757A1 (pt)
BR (1) BRPI0907595A2 (pt)
CA (1) CA2715822A1 (pt)
MX (1) MX2010009104A (pt)
WO (1) WO2009103727A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526005B (zh) * 2011-12-23 2013-07-10 苏州大学 甲磺酸去铁胺在制备治疗绝经后骨质疏松疾病药物中的用途
CN104997777A (zh) * 2015-07-24 2015-10-28 孔小乐 去铁酮的2比1锌络合物作为制备抗癌药物的应用
JP6793652B2 (ja) * 2015-09-03 2020-12-02 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
US20230192879A1 (en) 2020-05-19 2023-06-22 Institut Curie Methods for the diagnosis and treatment of cytokine release syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1497268A4 (en) * 2002-04-05 2006-01-18 Nitromed Inc NITROGEN OXIDE DISPENSER, COMPOSITIONS AND METHOD OF USE
KR20120068035A (ko) * 2002-12-09 2012-06-26 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
WO2007128820A1 (en) * 2006-05-09 2007-11-15 Novartis Ag Combination comprising an iron chelator and an anti-neoplastic agent and use thereof

Also Published As

Publication number Publication date
CN101945668A (zh) 2011-01-12
AU2009216757A1 (en) 2009-08-27
CA2715822A1 (en) 2009-08-27
JP2011512383A (ja) 2011-04-21
WO2009103727A3 (en) 2010-07-15
US20110009340A1 (en) 2011-01-13
EP2254599A2 (en) 2010-12-01
KR20100126386A (ko) 2010-12-01
WO2009103727A2 (en) 2009-08-27
MX2010009104A (es) 2010-09-09

Similar Documents

Publication Publication Date Title
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
SMT201600278B (it) Inibitori della benzossazolo chinasi e metodi d'uso
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BRPI0808444A2 (pt) análogos de ciclopamina lactam e métodos de uso dos mesmos
BR112012024120A2 (pt) sarms e método de uso dos mesmos
BRPI1005292A2 (pt) composição de decapagem e uso da composição
SMT201400181B (it) Composizioni per vasocostrizione e metodi d'uso
BRPI0909077A2 (pt) Artigos multicamadas e métodos de preparo e uso dos mesmos
PT2424372T (pt) Composições antimicrobianas e métodos de uso relacionados
DOP2011000059A (es) Composiciones de antagonistas de pd-1 y metodos de uso
BRPI0822229A2 (pt) Coacervados de complexos adesivo e métodos de fabricação e uso dos mesmos
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BR112012003661A2 (pt) "compostos de biarila e métodos de uso dos mesmos."
BRPI0915231A2 (pt) compostos inibidores de quinase e métodos de uso
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
BRPI0906980A2 (pt) Composição de derivados e maleatados
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
BRPI0913726A2 (pt) rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos
BRPI0922840A2 (pt) complexos de tecnécio e rênio-bis(heteroarila) e métodos de uso dos mesmos
BRPI0906490A2 (pt) Vetores de expressão de mamífero melhorados e uso dos mesmos
BRPI0906435A2 (pt) anticorpos anti-cd79b e imunoconjugados e métodos de uso
BRPI0915717A2 (pt) ferramenta de avaliação de cascalho e métodos de uso

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.